Paul Bollyky
@pbollyky.bsky.social
Stanford University Infectious Disease Doc studying bacteriophages, bacterial infections, and innate immunity.
Check it out - phages seem to cross the placenta from mom to fetus! Check it out here: insight.jci.org/articles/vie...
Congrats to Jen Sequioia, Naomi Haddock and our terrific collaborators in the Winn Lab
Congrats to Jen Sequioia, Naomi Haddock and our terrific collaborators in the Winn Lab
July 9, 2025 at 9:26 PM
Check it out - phages seem to cross the placenta from mom to fetus! Check it out here: insight.jci.org/articles/vie...
Congrats to Jen Sequioia, Naomi Haddock and our terrific collaborators in the Winn Lab
Congrats to Jen Sequioia, Naomi Haddock and our terrific collaborators in the Winn Lab
Very excited to see this preprint from @JasonAndrewsMD on a method using phages to detect environmental pathogens - this is a terrific idea
www.medrxiv.org/content/10.1...
www.medrxiv.org/content/10.1...
January 23, 2025 at 7:18 AM
Very excited to see this preprint from @JasonAndrewsMD on a method using phages to detect environmental pathogens - this is a terrific idea
www.medrxiv.org/content/10.1...
www.medrxiv.org/content/10.1...
Enjoyed reading these encouraging results from a new phage therapy trial in diabetic foot ulcers.
www.cell.com/med/abstract...
www.cell.com/med/abstract...
Randomized double-blind study on safety and tolerability of TP-102 phage cocktail in patients with infected and non-infected diabetic foot ulcers
The bacteriophage formulation TP-102 was tested in a phase I/IIa clinical trial and was well tolerated. No significant adverse events were observed, suggesting its therapeutic potential for bacterial infections in diabetic foot ulcers.
www.cell.com
January 6, 2025 at 6:51 PM
Enjoyed reading these encouraging results from a new phage therapy trial in diabetic foot ulcers.
www.cell.com/med/abstract...
www.cell.com/med/abstract...
I'm thrilled to welcome our new class of Infectious Disease fellows to Stanford! We are so excited have such a talented group of physicians coming to join us next year.
December 7, 2024 at 6:43 PM
I'm thrilled to welcome our new class of Infectious Disease fellows to Stanford! We are so excited have such a talented group of physicians coming to join us next year.
Excited to share our work on broadly effective phage-antibiotic cocktails. We report 4 cocktails that each work against 96% of 153 antibiotic resistant Pseudomonas isolates. Check it out here: www.nature.com/articles/s41... Congrats to Kevin Kim @KevinMinyo6651
A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections - Nature Communications
The application of phage therapy for multidrug-resistant infections is mainly limited to personalized therapy due to the narrow host range of individual phages. Here, Kim et al. identify groups of pha...
www.nature.com
December 2, 2024 at 6:36 AM
Excited to share our work on broadly effective phage-antibiotic cocktails. We report 4 cocktails that each work against 96% of 153 antibiotic resistant Pseudomonas isolates. Check it out here: www.nature.com/articles/s41... Congrats to Kevin Kim @KevinMinyo6651